Hôpital de la Timone- AP-HM

Marseille

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Non-Small Cell Lung Cancer

Studies at this site

• Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) — Running, not enrolling
• IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors — Stopped early